AUM Biosciences
Signal active
Organization
Contact Information
Overview
AUM Biosciences is an oncology-focused biotechnology company that aims to accelerate the development of innovative, affordable medicines for patients in Asia and around the world. AUM Biosciences focuses on early-stage development of innovative medicines for the treatment of Asian-prevalent cancers.
About
Industries
Biotechnology, Oncology
Founded
2018
Employees
11-50
Headquarters locations
Asia
Social
N/A
Profile Resume
AUM Biosciences headquartered in Asia, operates in the Biotechnology, Oncology sector. The company focuses on Biotechnology and has secured $455.8M in funding across 16 round(s). With a team of 11-50 employees, AUM Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - AUM Biosciences, raised $27.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
3
Lead Investors
0
Total Funding Amount
$28.5M
Details
2
AUM Biosciences has raised a total of $28.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Seed | 1.5M | ||
| 2021 | Early Stage Venture | 27.0M |
Investors
AUM Biosciences is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| AUM Biosciences | - | FUNDING ROUND - AUM Biosciences | 27.0M |
| Everlife | - | FUNDING ROUND - Everlife | 27.0M |
| AUM Biosciences | - | FUNDING ROUND - AUM Biosciences | 27.0M |
| The Agency for Science, Technology and Research | - | FUNDING ROUND - The Agency for Science, Technology and Research | 27.0M |
Recent Activity
There is no recent news or activity for this profile.